Evidence map›Paper›PMID 36808045›Full record

ArticleJournal of clinical psychology in medical settings2023

Web-Based Cognitive-Behavioral Therapy to Reduce Severe Cancer-Related Fatigue Among Survivors of Hodgkin Lymphoma: A Feasibility Study.

Peter Esser, Horst Müller, Peter Borchmann, Stefanie Kreissl, Hans Knoop, Uwe Platzbecker, Vladan Vucinic, Anja Mehnert-Theuerkauf

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of clinical psychology in medical settings, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03968250 (Cognitive Behavioral Therapy), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03968250 nacompletednot on this map

Cognitive Behavioral Therapy (CBT) Web-based Intervention on Fatigue in Survivors of Hodgkin Lymphoma - a Pilot Study

TypeinterventionalSponsorUniversity of LeipzigRan2018 to 2021Enrolled17ConditionsHodgkin Lymphoma, FatigueArmsCognitive Behavioral Therapy for Treating Fatigue
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Peter EsserDepartment of Medical Psychology and Medical Sociology, University of Leipzig, Philipp-Rosenthal-Straße 55, 04103, Leipzig, Germany. peter.esser@medizin.uni-leipzig.de.ORCID 0000-0002-4944-8020
Horst MüllerGerman Hodgkin Study Group (GHSG), Clinic I for Internal Medicine at the University Medical Center of Cologne, Cologne, Germany.
Peter BorchmannGerman Hodgkin Study Group (GHSG), Clinic I for Internal Medicine at the University Medical Center of Cologne, Cologne, Germany.
Stefanie KreisslGerman Hodgkin Study Group (GHSG), Clinic I for Internal Medicine at the University Medical Center of Cologne, Cologne, Germany.
Hans KnoopDepartment of Medical Psychology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.
Uwe PlatzbeckerClinic for Hematology, Cellular Therapy and Hemostaseology, University Medical Center Leipzig, Leipzig, Germany.
Vladan VucinicClinic for Hematology, Cellular Therapy and Hemostaseology, University Medical Center Leipzig, Leipzig, Germany.
Anja Mehnert-TheuerkaufDepartment of Medical Psychology and Medical Sociology, University of Leipzig, Philipp-Rosenthal-Straße 55, 04103, Leipzig, Germany.
University Hospital Cologne · DELeipzig University · DEUniversity Hospital Leipzig · DEAmsterdam University Medical Centers · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the feasibility of a web-based cognitive-behavioral therapy to reduce cancer-related fatigue (CRF) among survivors of Hodgkin lymphoma. In this before-and-after trial, patients were primarily recruited via the German Hodgkin Study Group (GHSG). We assessed feasibility (response and drop-out rate) and preliminary efficacy including CRF, quality of life (QoL), and depressive symptomatology. T tests compared baseline levels with t1 (post treatment) and t2 (3 months of follow-up). Among 79 patients contacted via the GHSG, 33 provided interest (42%). Among the seventeen participants, four were treated face-to-face (pilot patients), 13 underwent the web-based version. Ten patients completed the treatment (41%). Among all participants, CRF, depressive symptomatology, and QoL improved at t1 (p ≤ .03). The effect in one of the CRF measures remained at t2 (p = .03). Except for QoL, post-treatment effects were replicated among the completers of the web-based version (p ≤ .04). The potential for this program has been demonstrated, but needs to be re-assessed after identified issues on feasibility have been resolved.Trial registration: The study was registered at ClinicalTrials.gov (Number: NCT03968250).

Indexed as

Cognitive Behavioral TherapyHodgkin DiseaseFatigueFeasibility StudiesHumansInternetQuality of LifeSurvivorsCancer-related fatigueCognitive-behavioral therapyHodgkin lymphomaOnline interventionsSurvivorship

Identifiers

PMID36808045
PMCPMC9943038
OpenAlexW4321435525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.